Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237.

MLA

Tayyar, Yaman, et al. “Development of an Intravaginal Ring for the Topical Delivery of Aurora Kinase A Inhibitor, MLN8237.” PloS One, vol. 14, no. 11, Nov. 2019, p. e0225774. EBSCOhost, https://doi.org/10.1371/journal.pone.0225774.

APA

Tayyar, Y., Shiels, R., Bulmer, A. C., Lam, A. K., Clarke, D., Idris, A., & McMillan, N. A. (2019). Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237. PloS One, 14(11), e0225774. https://doi.org/10.1371/journal.pone.0225774

Chicago

Tayyar, Yaman, Ryan Shiels, Andrew C Bulmer, Alfred K Lam, Daniel Clarke, Adi Idris, and Nigel A McMillan. 2019. “Development of an Intravaginal Ring for the Topical Delivery of Aurora Kinase A Inhibitor, MLN8237.” PloS One 14 (11): e0225774. doi:10.1371/journal.pone.0225774.